TwinBeech Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,444
Closed -$529K 830
2022
Q3
$529K Buy
10,444
+2,499
+31% +$125K 0.01% 519
2022
Q2
$362K Buy
+7,945
New +$355K 0.02% 441
2022
Q1
Sell
-9,266
Closed -$465K 641
2021
Q4
$465K Buy
+9,266
New +$479K 0.03% 430

Other funds holding LMAT

TwinBeech Capital's LMAT Position: Q4 2022 in Review

TwinBeech Capital sold out of LeMaitre Vascular (LMAT) in Q4 2022, closing a stake of 10,444 shares — an estimated $529K sold.

TwinBeech Capital first reported a position in LMAT in Q4 2021 and held it in 3 quarters. The position peaked at $529K in Q3 2022. 182 funds tracked by Wall St. Rank hold LMAT as of Q4 2022.

  • TwinBeech Capital reported no remaining LeMaitre Vascular position as of Q4 2022 after selling out during the quarter.
  • TwinBeech Capital sold 10,444 LeMaitre Vascular shares in Q4 2022, an estimated $529K.
  • TwinBeech Capital first reported a position in LeMaitre Vascular in Q4 2021 and held it in 3 quarters.
  • TwinBeech Capital's LeMaitre Vascular position peaked at $529K in Q3 2022.
  • 182 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2022.

Based on TwinBeech Capital's 13F filing for Q4 2022, filed 14 Feb 2023.